The Emerade 300 and 500 microgram auto-injector pens, which are used to treat anaphylaxis, have been recalled by regulators. All Emerade 300 and 500 adrenaline pens are being withdrawn. More info 👉 https://t.co/vEDOEwpIuq pic.twitter.com/JBkmsjy2VS — MHRAgovuk (@MHRAgovuk) May 9, 2023Patients have been told to return their Emerade pens only once they have been given a replacement as a recall is issued. Similar concerns have been raised about Emerade products in the past. We are taking prompt action to protect patients, following detection of damage to internal components of the Emerade pens if they are dropped, which may mean they activate too early or fail to activate and deliver adrenaline.

Source: Express May 10, 2023 02:01 UTC